VOGLIBOSE 0.3mg. IP + METFORMIN 500mg. IP

An antihyperglycemic agent that controls blood glucose levels effectively. (Tae Jung Oh J. M., 2019) Delays the digestion as well as absorption of carbohydrates and inhibits postprandial hyperglycemia. (Xiaolong Chen, 2006) An effective and well-tolerated drug in a wide range of type 2 diabetic Mellitus patients. (Ajay S. Dabhi, 2013) Reduces the development of type 2 diabetes in high-risk individuals with impaired glucose tolerance. (Ryuzo Kawamori, 2009) A safe antihyperglycemic agent that effectively controls blood glucose level. (Tae Jung Oh, 2019) A good option in initial therapy for subjects with type 2 diabetes mellitus. (Tae Jung Oh J. M., 2019) An alternative therapeutic option for patients with Type 2 diabetes mellitus in which glycemic control is inadequate. (Ajay S. Dabhi, 2013) Provides superior glycemic control for HbA1c, postprandial glucose, and fasting plasma glucose levels than metformin monotherapy in patients with type 2 diabetes. (Tae Jung Oh J. M., 2019) More effective option for overweight or obese individuals with type 2 diabetes. (Tae Jung Oh J. M., 2019)